Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications

Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications

Julie-Anne Tanner,1,2 Lisa C Brown,3 Kunbo Yu,3 James Li,3 Bryan M Dechairo4 1Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Department of Psychiatry, Toronto, ON, Canada; 2Assurex Health Ltd., Toronto, ON, Cana...

Full description

Bibliographic Details
Main Authors: Tanner JA, Brown LC, Yu K, Li J, Dechairo BM
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
pharmacogenomics
genetic test
psychiatry
mental health
prescription
pharmacy spend
Online Access:https://www.dovepress.com/canadian-medication-cost-savings-associated-with-combinatorial-pharmac-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/canadian-medication-cost-savings-associated-with-combinatorial-pharmac-peer-reviewed-article-CEOR

Similar Items